Results 271 to 280 of about 3,407,466 (313)

Microsatellite DNA markers for rice chromosomes

TAG Theoretical and Applied Genetics, 1996
We found 369 complete microsatellites, of which (CGG/GCC)n was the most frequent, in 11 798 rice sequences in the database. Of these microsatellites, 35 out of 45 could be successfully converted into microsatellite DNA markers using sequence information in their flanking regions.
H, Akagi, Y, Yokozeki, A, Inagaki, T, Fujimura   +3 more
openaire   +2 more sources

DNA methylation markers in colorectal cancer

Cancer and Metastasis Reviews, 2010
Colorectal cancer (CRC) arises as a consequence of the accumulation of genetic and epigenetic alterations in colonic epithelial cells during neoplastic transformation. Epigenetic modifications, particularly DNA methylation in selected gene promoters, are recognized as common molecular alterations in human tumors.
Myoung Sook, Kim, Juna, Lee, David, Sidransky   +2 more
openaire   +2 more sources

DNA Methylation As a Clinical Marker in Oncology

Journal of Clinical Oncology, 2012
Personalized oncology is critically dependent on accurate measurement of biomarkers in cancer tissues or surrogate tissues if appropriate. Historically, the field started with protein biomarkers such as hormonal status in breast cancer and genetic biomarkers such as chromosomal changes in the management of patients with acute myeloid leukemia.
openaire   +2 more sources

The power and the promise of DNA methylation markers

Nature Reviews Cancer, 2003
The past few years have seen an explosion of interest in the epigenetics of cancer. This has been a consequence of both the exciting coalescence of the chromatin and DNA methylation fields, and the realization that DNA methylation changes are involved in human malignancies.
openaire   +2 more sources

Therapeutics and DNA Methylation Inhibitors

Medical Epigenetics, 2021
Shyamala C Navada
exaly  

Circulating Tumor DNA in Advanced Solid Tumors: Clinical Relevance and Future Directions

Ca-A Cancer Journal for Clinicians, 2021
Heather Parsons, Atish D. Choudhury, Michael L Cheng   +2 more
exaly  

Marker (DNA Marker)

2008
George Hangay, Susan V. Gruner, F. W. Howard, John L. Capinera, Eugene J. Gerberg, Susan E. Halbert, John B. Heppner, Peter Neuenschwander, Kurt Redborg, John B. Heppner, Lanna Cheng, Allan T. Showler, Ronald J. Prokopy, JosE Roberto Postali Parra, George Hangay, Boris Kondratieff, Igor Uspensky, John B. Heppner, John B. Heppner, Nikos T. Papadopoulos, Marjorie A. Hoy, Timothy A. Ebert, John L. Capinera, John L. Capinera, M. Patricia Juárez, Jason P. W. Hall, John B. Heppner, Judith H. Willis, John S. Willis, Michael Bidochka, Wendell L. Morrill, B. Merle Shepard, John L. Capinera, Lawrence A. Lacey, Lawrence A. Lacey, James J. Becnel, Gregory S. Paulson, Leellen F. Solter, Meir Broza, Ping Wang, John L. Capinera, George Hangay, Heather J. McAuslane, John B. Heppner, David R. Horton, Chyi-Chen Ho, Lewis B. Coons, Marjorie Rothschild, J. Howard Frank, Norman C. Leppla, Maria Navajas, George Roderick, John B. Heppner, Thomas C. Emmel, Andrei Sourakov, John L. Capinera, John R. Wallace, John R. Wallace, Christopher Tipping, Richard G. Weber, C. Roxanne Rutledge, Ann M. Powers, Aaron C. Brault, Barry R. Miller, John B. Heppner, Barbara Bentz, Severiano F. Gayubo, Murray S. Blum, L. T. Kok, M. D. Soler Cruz, James McIver, Gary Stonedahl, James A. Danoff-Burg, Ron Cherry   +73 more
openaire   +1 more source

Epigenetics of Skin Disorders

Medical Epigenetics, 2021
Qianjin Lu, Shuaihantian Luo
exaly  

Clinical Utility of Solid Tumor Epigenetics

Medical Epigenetics, 2021
Sevin Turcan, Julian Taranda
exaly  

Polymorphic DNA Markers in Entamoeba histolytica

Archives of Medical Research, 2000
M, Zaki, C G, Clark
openaire   +2 more sources